Listed

CSP Inc: Form 10-Q for the period ended Mar 31, 2025

Filed with the SEC on May 15, 2025 and accepted by EDGAR at May 15, 2025, 10:04 ET.

Share

Management's discussion and analysis

As filed, 36,733 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statements

The discussion below contains certain forward-looking statements including, but not limited to, among others, statements concerning future revenues and future business plans. Forward-looking statements include statements in which we use words such as “expect”, “believe”, “anticipate”, “intend”, “project”, “estimate”, “should”, “could”, “may”, “plan”, “potential”, “predict”, “project”, “will”, “would” and similar expressions. Although we believe the expectations reflected in such forward-looking statements are based on reasonable assumptions, the forward-looking statements are subject to significant risks and uncertainties, and thus we cannot assure you that these expectations will prove to have been correct, and actual results may vary from those contained in such forward-looking statements. We discuss many of these risks and uncertainties in Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024. An additional risk factor can be found within this Form 10-Q under Item 1A under the heading “Risk Factors.” Factors that may cause such variances include, but are not limited to, our dependence on a small number of customers for a significant portion of our revenue, intense competition in the market segments in which we operate, changes in the U.S. Tax laws, the impact of the Ukrainian-Russian military and Israeli-Hamas conflict on global trade and financial markets, and the impact of pandemics on our business, tariffs, results of operations and financial condition. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our estimates and assumptions only as of the date of this document. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statements contained in this report, whether as a result of new information, future events or otherwise. This management’s discussion and analysis of financial condition and results of operations should be read in conjunction with our financial statements and the related notes included elsewhere in this filing and in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our estimates, including those related to the allowance for credit losses for accounts receivable and financing receivables, inventory valuation, impairment assessment of intangibles, income taxes, deferred compensation and retirement plans, as well as estimated selling prices used for revenue recognition and contingencies. We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. A description of our critical accounting policies is contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024 in the “Critical Accounting Policies” section contained in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations. Management believes there have been no significant changes for the three months ended March 31, 2025 to the items that we disclosed as our critical accounting estimates in the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

Recent trends affecting our financial performance

As of March 31, 2025, the Russian/Ukrainian military conflict and the Israeli-Hamas conflict have not had a direct significant impact on revenue as we do not have any significant recurring customers in either region. However, we do have customers and suppliers in surrounding regions which may be affected and further escalation of both conflicts and geopolitical tensions related to such conflicts could adversely affect our business, financial condition and results of operations, by among other things, cyberattacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets. It is not possible at this time to predict the size of the impact or consequences of the conflicts on the Company and our customers or suppliers.

Results of Operations

Overview of the three months ended March 31, 2025

Our sales decreased by $0.6 million, or 4%, to $13.1 million for the three months ended March 31, 2025 compared to $13.7 million for the three months ended March 31, 2024. Our gross margin percentage decreased to 32% for the three months ended March 31, 2025 compared to 47% for the three months ended March 31, 2024. For the three months ended March 31, 2025 there was an operating loss of $1.0 million compared to operating income of $1.2 million for the three months ended March 31, 2024. Other income, net decreased $0.3 million to $0.2 million for the three months ended March 31, 2025 compared to $0.5 million for the same prior year period. An income tax benefit of $0.7 million was recorded for the three months ended March 31, 2025 compared to an income tax expense of $0.1 million in the same period in the prior year.

The following table details our results of operations in dollars and as a percentage of sales for the three months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​ ​ ​% ​ of sales ​ ​ ​ ​ March 31, 2024 ​ ​ ​ ​% ​ of sales
Sales ​ $13,147 100% $13,706 100%
Costs and expenses: ​ ​ ​
Cost of sales ​ 8,940 68% 7,228 53%
Engineering and development ​ 763 6% 726 5%
Selling, general and administrative ​ 4,438 34% 4,518 33%
Total costs and expenses ​ 14,141 108% 12,472 91%
Operating (loss) income ​ (994) (8)% 1,234 9%
Other income, net ​ 203 2% 489 4%
(Loss) income before income taxes ​ (791) (6)% 1,723 13%
Income tax (benefit) expense ​ (683) (5)% 135 1%
Net (loss) income ​ $(108) (1)% $1,588 12%

Sales

Our sales decreased by approximately $0.6 million, or 4%, to $13.1 million for the three months ended March 31, 2025 compared to $13.7 million for the same prior year period. The decrease in sales is the result of a decrease of $1.9 million in our HPP segment, partially offset by a $1.3 million increase in our TS segment.

TS segment sales change was as follows for the three months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​ ​ 2024 ​ ​ ​ ​ Increase (decrease) $% ​ ​ ​ ​
Products ​ $8,279 ​ $6,415 ​ $1,864 ​ 29%
Services ​ 4,221 ​ 4,789 ​ (568) ​ (12)%
Total ​ $12,500 ​ $11,204 ​ $1,296 ​ 12%

The increase in TS segment product sales of $1.9 million is due to increased sales to several existing major customers in the US division of $1.5 million and the UK division of $0.4 million. Service sales for the three months ended March 31, 2025 decreased $0.6 million from the same prior year period, which was attributable to the US division. The decrease in service sales included decreased third-party maintenance sales of $0.9 million, partially offset by increased managed services sales of $0.2 million and increased internal and third-party services of $0.1 million.

HPP segment sales change was as follows for the three months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​ ​ 2024 ​ ​ ​ ​ Decrease $% ​ ​ ​ ​
Products ​ $273 ​ $2,043 ​ $(1,770) ​ (87)%
Services ​ 374 ​ 459 ​ (85) ​ (19)%
Total ​ $647 ​ $2,502 ​ $(1,855) ​ (74)%

The HPP product sales decreased $1.8 million for the three months ended March 31, 2025 compared to the same prior year period as a result of one decreased sale of ARIA Zero Trust Gateway to one major customer of $2.0 million in the prior year not recurring in the current year period, partially offset by increased ARIA Zero Trust Gateway sales to new customers of $0.2 million. The HPP service sales decreased $0.1 million due to decreased royalties of $0.2 million, partially offset by $0.1 million increased ARIA AZT customer support revenue.

Our sales by geographic area, which are based on the customer location to which the products were shipped or services rendered, were as follows for the three months ended March 31, 2025 and 2024:

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ Increase (decrease)
​ 2025% 2024% $%
​ ​ (Dollar amounts in thousands) ​
Americas ​ $12,343 94% $13,530 99% $(1,187) ​ (9)%
Europe ​ 655 5% 154 1% 501 ​ 325%
APAC and Africa ​ 149 1% 22 —% 127 ​ 577%
Totals ​ $13,147 100% $13,706 100% $(559) ​ (4)%

The $1.2 million decrease in sales to the Americas was primarily the result of a $2.0 million decrease in the HPP segment, partially offset by an increase in the TS segment’s US division of $0.8 million. The $0.5 million increase in sales to Europe was primarily the result of increased sales by our TS segment’s UK division of $0.4 million and the US division of $0.1 million. The sales to APAC and Africa increased $0.1 million for the three months ended March 31, 2025 compared to the same prior year period due to an increase in the HPP segment expanding its ARIA AZT sales in the region.

Gross Margins

Our gross margin ("GM") decreased $2.3 million for the three months ended March 31, 2025 as compared to the same prior year period. The GM as a percentage of sales decreased to 32% for the three months ended March 31, 2025 compared to the same prior year period of 47%.

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Decrease GM$ ​ ​ ​ ​ ​ ​ GM% ​
TS ​ $3,836 31% $4,314 39% $(478) (8)%
HPP ​ 371 57% 2,164 86% (1,793) (29)%
Total ​ $4,207 32% $6,478 47% $(2,271) (15)%

The impact of product mix within our TS segment on gross margin for the three months ended March 31, 2025 and 2024 was as follows:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Increase (decrease) GM$ ​ ​ ​ ​ ​ ​ GM% ​
Products ​ $1,500 18% $1,210 19% $290 (1)%
Services ​ 2,336 55% 3,104 65% (768) (10)%
Total ​ $3,836 31% $4,314 39% $(478) (8)%

The overall TS segment GM as a percentage of sales decreased to 31% for the three month period ended March 31, 2025 compared to 39% for the same prior year period. Product GM as a percentage of revenue decreased 1% due to a different product mix without any significant changes from the prior year period. The service GM as a percentage of revenue decreased 10% from the prior year due to decreased third-party maintenance sales, which are recorded “net” meaning the revenue, net of the associated cost, is recorded in the Services revenue financial statement line item causing an increase in GM as a percentage of sales.

The impact of product mix within our HPP segment on gross margin for the three months ended March 31, 2025 and 2024 was as follows:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Decrease GM$ ​ ​ ​ ​ ​ ​ GM% ​
Products ​ $173 63% $1,832 90% $(1,659) (27)%
Services ​ 198 53% 332 72% (134) (19)%
Total ​ $371 57% $2,164 86% $(1,793) (29)%

The overall HPP segment GM as a percentage of sales decreased to 57% for the three months ended March 31, 2025 from 86% for the three months ended March 31, 2024. The 27% decrease in product GM as a percentage of product revenue for the three months ended March 31, 2025 compared to the same prior year period is due to one large ARIA Zero Trust Gateway order in the prior year period, which did not recur in the current period. The large ARIA Zero Trust Gateway order in the prior year was nearly all GM. The service GM as a percentage of services revenue from the same prior year period decreased 19% to 53% for the three months ended March 31, 2025 compared to 72% for the three months ended March 31, 2024 due to decreased royalty sales, which are nearly all GM.

Engineering and Development Expenses

The engineering and development expenses incurred by our HPP segment remained relatively flat for the three months ended March 31, 2025 compared to the prior year period without any significant changes in the expense mix. The current period expenses were primarily for product engineering expenses incurred in connection with the continued development of the ARIA Zero Trust Gateway cyber security products.

Selling, General and Administrative Expenses

The following table details our selling, general and administrative (“SG&A”) expense by operating segment for the three months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ By Operating Segment: ​ ​ ​ ​ ​ ​ Three months ended March 31, ​ ​ 2025 ​ ​ ​ ​ ​ % of ​ Total ​ ​ ​ ​ 2024 ​ ​ ​ ​ ​ ​ % of ​ Total ​ ​ ​ $​% ​ Increase ​ (Decrease) ​ ​ ​ ​ ​ Increase ​ (Decrease) ​ ​ ​
TS segment ​ $3,264 74% $3,345 74% $(81) (2)%
HPP segment ​ 1,174 26% 1,173 26% 1 —%
Total ​ $4,438 100% $4,518 100% $(80) (2)%

SG&A expenses decreased $0.1 million to $4.4 million for the three months ended March 31, 2025 compared to the same prior year period. The $0.1 million decrease in TS segment SG&A expenses compared to the same prior year period is primarily the result of decreased variable compensation. The HPP segment SG&A expenses remained relatively flat at $1.2 million the three months ended March 31, 2025 as compared to the prior year period due to increased salaries of $0.1 million, which was offset by decreased commissions of $0.1 million.

Other Income/Expenses

The following table details other income, net for the three months ended March 31, 2025 and 2024:

(Amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three months ended ​ ​ March 31, 2025 ​ ​ ​ ​ ​ ​ March 31, 2024 ​ ​ ​ ​ ​ ​ ​ ​ $ Change
Foreign exchange gain (loss) ​ $(132) ​ $32 ​ $(164)
Interest expense ​ ​ (77) ​ ​ (46) ​ ​ (31)
Interest income ​ 414 ​ 478 ​ (64)
Other income, net ​ (2) ​ 25 ​ (27)
Total other income, net ​ $203 ​ $489 ​ $(286)

Total other income, net for the three months ended March 31, 2025 was $0.2 million compared to $0.5 million for the three months ended March 31, 2024.

The $0.2 million decreased foreign exchange loss for the three months ended March 31, 2025 was primarily due to the US Dollar weakening relative to the British Pound compared to the same prior year period. In consolidation, US dollars are remeasured into the functional currency, British Pounds, of our UK subsidiary. This non-cash remeasurement is included in the foreign exchange gain (loss) in the Consolidated Statements of Operations. The foreign exchange loss was primarily from the US Dollar bank account in our TS UK division.

Interest income decreased $64 thousand for the three months ended March 31, 2025 compared to the same prior year period primarily due to decreased interest income from agreements that have payment terms in excess of one year (see Note 5 Financing receivables, net in Item 1 to this Quarterly Report on Form 10-Q for details). Although new agreements with higher interest rates have been entered into during fiscal 2024 and 2025, this is more than offset by lower interest income recognized from a larger number of prior agreements because interest income decreases from each agreement as time elapses due to principal payments being received. All of these agreements are in the TS-US division.

The interest expense increase of $31 thousand for the three months ended March 31, 2025 compared to the same prior year period was related to the TS US division entering into additional multi-year vendor contracts related to sales agreements that have payment terms in excess of one year during fiscal years 2024 and 2025. Interest expense increased while interest income decreased because many of the Company’s financing sales prior to fiscal year 2024 did not have vendor financing, but in fiscal years 2024 and 2025 vendor financing became more prevalent.

Income Taxes

The Company recorded an income tax benefit of $683 thousand and income tax expense of $135 thousand for the three months ended March 31, 2025 and 2024, respectively. The income tax benefit for the three months ended March 31, 2025 was primarily driven by the impact of tax credits that we expect to be able to utilize against federal and state taxes and the excess tax benefits on restricted stock awards vested during the period. The income tax expense for the three months ended March 31, 2024 was primarily driven by income earned in the United States.

Overview of the six months ended March 31, 2025

Our sales decreased by $0.3 million, or 1%, to $28.8 million for the six months ended March 31, 2025 as compared to $29.1 million for the six months ended March 31, 2024. The decrease in sales is the result of a decrease of approximately $2.2 million in our HPP segment, partially offset by an increase of $1.9 million in the TS segment. Our gross margin percentage decreased 6% to 30% of sales for the six months ended March 31, 2025 compared to 36% for the six months ended March 31, 2024. For the six months ended March 31, 2025 operating loss was $1.3 million compared to operating income of $0.9 million for the six months ended March 31, 2024. Other income, net increased $0.1 million for the six months ended March 31, 2025 compared to the six months ended March 31, 2024. An income tax benefit of $0.8 million was recorded for the six months ended March 31, 2025 compared to an income tax expense of $0.1 million in the same prior year period.

The following table details our results of operations in dollars and as a percentage of sales for the six months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​% ​ ​ ​ of sales ​ ​ ​ ​ March 31, 2024 ​ ​% ​ ​ of sales
Sales ​ $28,817 100% $29,081 100%
Costs and expenses: ​ ​ ​
Cost of sales ​ 20,046 70% 18,508 64%
Engineering and development ​ 1,549 5% 1,426 5%
Selling, general and administrative ​ 8,570 30% 8,256 28%
Total costs and expenses ​ 30,165 105% 28,190 97%
Operating (loss) income ​ (1,348) (5)% 891 3%
Other income, net ​ 914 3% 772 3%
(Loss) income before income taxes ​ (434) (2)% 1,663 6%
Income tax (benefit) expense ​ (798) (3)% 148 1%
Net income ​ $364 ​ 1% $1,515 ​ 5%

Sales

Our sales decreased by approximately $0.3 million, or 1%, to $28.8 million for the six months ended March 31, 2025 as compared to $29.1 million for the six months ended March 31, 2024. The decrease in sales is the result of a decrease of approximately $2.2 million in our HPP segment, partially offset by an increase of $1.9 million in the TS segment.

TS segment sales change was as follows for the six months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​ ​ 2024 ​ ​ ​ ​ Increase $% ​ ​ ​ ​
Products ​ $19,212 ​ $17,350 ​ $1,862 ​ 11%
Services ​ 8,528 ​ 8,517 ​ 11 ​ —%
Total ​ $27,740 ​ $25,867 ​ $1,873 ​ 7%

The increase in TS segment product sales of $1.9 million during the period as compared to the prior year period is attributable to increased sales of $1.7 million to several existing major customers in the US division combined with an increase in sales of $0.2 million in the UK division to existing customers. Service sales for the six months ended March 31, 2025 remained relatively flat from the prior year period with changes in the mix of revenue including an increase of $0.2 million from internal and third-party services and an increase in managed services of $0.1 million, offset by a decrease in third-party services of $0.3 million. All of these service sales changes occurred in the US division.

HPP segment sales change was as follows for the six months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 ​ ​ ​ 2024 ​ ​ ​ Increase (decrease) $% ​ ​ ​ ​ ​
Products ​ $355 ​ $2,515 ​ $(2,160) ​ (86)%
Services ​ 722 ​ 699 ​ 23 ​ 3%
Total ​ $1,077 ​ $3,214 ​ $(2,137) ​ (66)%

The HPP product sales decreased by $2.2 million for the six months ended March 31, 2025 as compared to the prior year period primarily as a result of one large ARIA AZT order of $2.0 million which occurred in the prior year period and did not recur in the current year combined with a $0.5 million decrease in Myricom sales, which was partially offset by increased ARIA AZT revenue to new customers of $0.3 million. The HPP service sales remained flat for the six months ended March 31, 2025 compared to the prior year period with changes in the mix of revenue including increased ARIA AZT customer support revenue of $0.2 million, which was offset by decreased revenue from royalties on high-speed processing boards related to the E2D program.

Our sales by geographic area, which are based on the customer location to which the products were shipped or services rendered, were as follows for the six months ended March 31, 2025 and 2024:

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, ​ Increase (decrease) ​
​ 2025% 2024% $%
​ ​ (Dollar amounts in thousands) ​
Americas ​ $27,827 96% $28,082 97% $(255) ​ (1)%
Europe ​ 836 3% 605 2% 231 ​ 38%
APAC and Africa ​ 154 1% 394 1% (240) ​ (61)%
Totals ​ $28,817 100% $29,081 100% $(264) ​ (1)%

The $0.3 million decrease in sales to the Americas was the result of a decrease in the HPP segment of $2.3 million, which was partially offset by the TS segment’s US division increase of $2.0 million. The sales to Europe increased $0.2 million due to increased sales in the TS US division of $0.1 million and the TS UK division of $0.1 million. The sales to APAC and Africa decreased $0.2 million as a result of decreased sales in the TS segment’s US division of $0.3 million, partially offset by increased sales in the HPP segment of $0.1 million.

Gross Margins

Our gross margin ("GM") decreased $1.8 million for the six months ended March 31, 2025 compared to the same prior year period. The GM as a percentage of total sales decreased to 30% for the six months ended March 31, 2025 as compared to the same prior year period of 36%.

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Increase (decrease) GM$ ​ ​ ​ ​ ​ ​ ​ GM%
TS ​ $8,185 30% $8,071 31% $114 (1)%
HPP ​ 586 54% 2,502 78% (1,916) (24)%
Total ​ $8,771 30% $10,573 36% $(1,802) (6)%

The impact of product mix within our TS segment on gross margin for the six months ended March 31, 2025 and 2024 was as follows:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Increase (decrease) GM$ ​ ​ ​ ​ ​ ​ GM% ​
Products ​ $3,336 17% $3,107 18% $229 (1)%
Services ​ 4,849 57% 4,964 58% (115) (1)%
Total ​ $8,185 30% $8,071 31% $114 (1)%

The overall TS segment GM as a percentage of total sales decreased to 30% for the six month period ended March 31, 2025 compared to 31% from the prior year period. Product GM as a percentage of revenue for the six months ended March 31, 2025 decreased 1% from the prior year period due to product mix. Service GM as a percentage of total sales decreased to 57% for the six months ended March 31, 2025 compared to 58% from the prior year period. This was primarily due to decreased third-party maintenance sales, which are recorded “net” meaning the revenue, net of the associated cost, is recorded in the Services revenue financial statement line item causing an increase in GM as a percentage of sales.

The impact of product mix within our HPP segment on gross margin for the six months ended March 31, 2025 and 2024 was as follows:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31, 2025 GM$ ​ ​ ​ ​ GM% ​ ​ 2024 GM$ ​ ​ ​ ​ ​ GM% ​ ​ ​ ​ Decrease GM$ ​ ​ ​ ​ ​ ​ ​ GM%
Products ​ $233 66% $2,114 84% $(1,881) (18)%
Services ​ 353 49% 388 56% (35) (7)%
Total ​ $586 54% $2,502 78% $(1,916) (24)%

The overall HPP segment GM as a percentage of sales decreased to 54% for the six months ended March 31, 2025 from 78% for the six months ended March 31, 2024. The 18% decrease in product GM as a percentage of product revenue compared to the same prior year period was primarily attributed to one large ARIA Zero Trust Gateway order in the prior year period, which was nearly all GM and did not recur in the current period. The 7% decrease in service GM as a percentage of service revenue for the six months ended March 31, 2025 compared to the same prior year period was due to decreased royalty sales, which are nearly all GM, partially offset by more AZT customer support GM.

Engineering and Development Expenses

The engineering and development expenses incurred by our HPP segment increased to $1.5 million for the six months ended March 31, 2025 compared to the same prior year period of $1.4 million due to increased consulting as the quantity of sales opportunities increased. The current period expenses were primarily for product engineering expenses incurred in connection with the continued development of the ARIA Zero Trust Gateway cyber security products.

Selling, General and Administrative Expenses

The following table details our selling, general and administrative (“SG&A”) expense by operating segment for the six months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ By Operating Segment: ​ ​ ​ ​ ​ ​ Six months ended March 31, ​ ​ 2025 ​ ​ ​ ​ ​ % of ​ Total ​ ​ ​ ​ 2024 ​ ​ ​ ​ ​ ​ % of ​ Total ​ ​ ​ ​ ​ $​% ​ Increase ​ ​ ​ ​ ​ ​ ​ ​ Increase ​ ​ ​
TS segment ​ $6,294 73% $6,100 74% $194 3%
HPP segment ​ 2,276 27% 2,156 26% 120 6%
Total ​ $8,570 100% $8,256 100% $314 4%

SG&A expenses increased $0.3 million for the six months ended March 31, 2025 compared to the same prior year period. The $0.2 million increase in TS segment SG&A expenses compared to the same prior year period is primarily the result of increased stock compensation expense. The HPP segment SG&A expenses increased $0.1 million for the six months ended March 31, 2025 as compared to the prior year period primarily due to increased stock compensation expense.

Other Income/Expenses

The following table details other income, net for the six months ended March 31, 2025 and 2024:

(Amounts in thousands)

​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Six months ended ​ ​ March 31, 2025 ​ ​ ​ ​ ​ ​ March 31, 2024 ​ ​ ​ ​ ​ ​ ​ ​ $ Change ​ ​ ​ ​ ​
Foreign exchange gain (loss) ​ $163 ​ $(142) ​ $305 ​
Interest expense ​ ​ (154) ​ ​ (95) ​ ​ (59) ​
Interest income ​ 903 ​ 974 ​ (71) ​
Other income, net ​ 2 ​ 35 ​ (33) ​
Total other income, net ​ $914 ​ $772 ​ $142 ​

Total other income, net for the six months ended March 31, 2025 increased $0.1 million to income of $0.9 million compared to income of $0.8 million in the same prior year period.

The $0.3 million increased foreign exchange gain for the six months ended March 31, 2025 was due to the US Dollar strengthening relative to the British Pound compared to the same prior year period. In consolidation, US dollars are remeasured into the functional currency, British Pounds, of our UK subsidiary. This non-cash remeasurement is included in the Foreign exchange gain (loss) in the Consolidated Statements of Operations. The foreign exchange gain in the current period was primarily from the US Dollar bank account in our TS UK division.

Interest income decreased $71 thousand for the six months ended March 31, 2025 compared to the same prior year period primarily due to decreased interest income from agreements that have payment terms in excess of one year (see Note 5 Financing receivables, net in Item 1 to this Quarterly Report on Form 10-Q for details). Although new agreements with higher interest rates have been entered into during fiscal years 2024 and 2025, this is more than offset by lower interest income recognized from a larger number of prior agreements because interest income decreases from each agreement as time elapses due to principal payments being received. All of these agreements are in the TS-US division.

The interest expense increase of $59 thousand for the three months ended March 31, 2025 compared to the same prior year period was primarily related to the TS US division entering into additional multi-year vendor contracts related to sales agreements in fiscal year 2025 that have payment terms in excess of one year. Interest expense increased while interest income decreased because many of the Company’s financing sales prior to fiscal year 2024 did not have vendor financing, but in fiscal years 2024 and 2025 vendor financing became more prevalent.

Income Taxes

The Company recorded an income tax benefit of $798 thousand and income tax expense of $148 thousand for the six months ended March 31, 2025 and 2024, respectively. The income tax benefit for the six months ended March 31, 2025 was primarily driven by the impact of tax credits that we expect to be able to utilize against federal and state taxes and the excess tax benefits on restricted stock awards vested during the period. The income tax expense for the six months ended March 31, 2024 was primarily driven by income earned in the United States.

Liquidity and Capital Resources

Our primary source of liquidity is our cash and cash equivalents and our line of credit.

Cash and cash equivalents decreased by $1.1 million to $29.5 million as of March 31, 2025 from $30.6 million as of September 30, 2024.

The following is a summary of our cash flows for the six months ended March 31, 2025 and 2024:

(Dollar amounts in thousands)

​ ​ ​ ​ ​ Net cash (used in) provided by: ​ ​ ​ ​ ​ ​ Six months ended March 31, ​ ​ 2025 ​ ​ ​ ​ ​ ​ ​ 2024 ​
Operating activities ​ $3,653 $3,324
Investing activities ​ ​ (108) ​ ​ (193)
Financing activities ​ ​ (4,603) ​ ​ (1,246)
Effect of exchange rate changes on cash ​ ​ (32) ​ ​ 17
(Decrease) increase in cash and cash equivalents ​ $(1,090) $1,902

Operating Activities

Cash provided by operating activities was $3.7 million for the six months ended March 31, 2025 compared to $3.3 million provided by operating activities in the prior year. The significant changes from the prior period include increased collections of Accounts receivable of $0.7 million, decreased payments in Accounts payable and accrued expenses of $1.2 million, partially offset by decreased collections of Financing receivables of $0.7 million and a decreased inventory change of $0.8 million. The remaining differences are primarily related to timing differences in operating assets and liabilities. Inventory fluctuations are dependent on when orders are received and shipped. Accounts payable and accrued expenses fluctuations are dependent on when vendor invoices are received as well as the related timing of the payments.

Investing Activities

Cash used in investing activities was $0.1 million for the six months ended March 31, 2025 compared to $0.2 million used in investing activities for the prior year period. The decrease in cash used from the prior year is due to decreased purchases of property, equipment, and improvements.

Financing Activities

Cash used in financing activities increased approximately $3.4 million from the prior year to $4.6 million for the six months ended March 31, 2025 compared to $1.2 million for the prior year period. The increase from the prior year was primarily due to increased net borrowing on our line-of-credit of approximately $3.2 million from the prior year, increased cash dividend payments of $0.2 million, repurchases of common stock of $0.4 million, partially offset by a decrease of a note payable of $0.4 million.

Other Liquidity and Capital Resources Items

Our cash held by our foreign subsidiary in the United Kingdom totaled approximately $4.6 million as of March 31, 2025 and consisted of 0.3 million Euros, 0.5 million British Pounds, and 3.6 million US Dollars. This cash is included in our total cash and cash equivalents reported on the Condensed Consolidated Balance Sheets.

As of March 31, 2025 and September 30, 2024, the Company maintained a line of credit with a capacity of up to $15.0 million for inventory accessible to both the HPP and TS segments. This line of credit also includes availability of a limited cash withdrawal of up to $1.0 million. An amount of $14.6 million and $10.8 million were available as of March 31, 2025 and September 30, 2024, respectively. As of March 31, 2025 and September 30, 2024 there were no cash withdrawals outstanding. For further discussion of the Company’s line of credit, including its financial covenants, see Item 1, Note 9 Line of Credit.

If cash generated from operations is insufficient to satisfy working capital requirements, we may need to access funds through bank loans or other means. If we are unable to secure additional financing, we may not be able to complete development or enhancement of products, take advantage of future opportunities, respond to competition, retain key employees, or continue to effectively operate our business.

Based on our current plans and business conditions, management believes that the Company’s available cash and cash equivalents, the cash generated from operations, and availability on our line of credit will be sufficient to provide for the Company’s working capital and capital expenditure requirements for at least 12 months from the date of this filing.

Controls and procedures

As filed, 8,975 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2025 based on the criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations (“COSO”) of the Treadway Commission (“2013 Framework”). Our Chief Executive Officer, our Chief Financial Officer and other members of our senior management team supervised and participated in this evaluation. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2025, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective, due to the fact that we are not yet able to conclude that the material weaknesses described in this Item 4 have been remediated by the changes we made in response to these material weaknesses.

As previously disclosed in Item 9A of our Annual Report on Form 10-K for the period ended September 30, 2024, our management identified two material weaknesses as of such date. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be able to be prevented or detected on a timely basis.

Material weakness 1 – Corporate credit cards

In August 2024 during its fiscal year 2024 third quarter review the Company identified certain control deficiencies related to its business expense reimbursement and selected purchases policy and application of a legacy credit card program for Company credit cards. The control deficiencies arose out of a lack of adequate review and incomplete supporting documentation related to certain business expenses including those for reimbursement for Company credit card charges from a C level Company executive as well as an undocumented compensation agreement with regards to the use of credit card points which resulted in undisclosed compensation. The Audit Committee engaged a third party to investigate and analyze certain transactions made on the corporate credit card and it was not led by management. As of September 30, 2024, the C-level executive returned to the Company approximately $20,000 in aggregate related to the portion of the undisclosed compensation in excess of the intended compensation agreement. There were no subsequent amounts of undisclosed compensation returned to the company.

In response to these control deficiencies, the Company performed additional analysis and reconciliation around all the credit card activity, including reimbursement, purchases and review of the credit card use policies, assessed various alternatives to remediate this material weakness and implemented changes to our internal controls including implementation of additional review and confirmation process by designated employees and the termination of the legacy benefit program identified above.

During the preparation of our annual financial statements, we determined that the controls over the credit card process were not operating effectively, and the resulting control gap amounted to a material weakness in our controls over financial reporting. As a result, we concluded that the Company’s internal control over financial reporting was not effective as of September 30, 2024. The COSO principles of Exercises oversight responsibility and develops control activities were not properly followed in our internal controls. Although we have implemented changes to our internal controls over financial reporting as described herein, as of March 31, 2025 we cannot conclude that the material weaknesses has been remediated.

Material weakness 2 – Income taxes

Management identified another material weakness in our internal controls over financial reporting for income taxes relating to current/non-current taxes payable, certain deferred tax assets and liabilities, and current and deferred tax expenses. We use a third-party provider to prepare our tax provision and related disclosures on a quarterly basis. The company reviews the provision and disclosures. We believe the material weakness occurred due to a lack of competency of the third-party provider and management needs to perform a more comprehensive review with the third-party preparer. Although we have implemented changes to our internal controls over financial reporting as described herein, as of March 31, 2025 we cannot conclude that the material weaknesses has been remediated.

Remediation of Material Weaknesses

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that the material weaknesses are remediated as soon as possible. We believe we have made progress towards remediation and continue to implement our remediation plan for the material weakness, which includes the following steps.

Material weakness 1 – Corporate credit cards

  • All points earned on the Company credit cards will accrue only to the benefit of the Company.
  • The Company updated its Credit Card purchase and Reimbursement Policy and has taken steps to ensure the Expense Policy is followed with documentation and proper approvals.
  • In fiscal year 2025, internal audit will test a reasonable number of selections from all corporate credit card expenses monthly and report findings directly to the Company’s CFO. If there is an exception, this will be reported to the Audit Committee
  • Quarterly a summary report of Credit card internal audit results will be reported to the Audit Committee.

Material weakness 2 – Income taxes

  • Hired a new accounting firm with global expertise as our new third-party tax provider to prepare tax provisions and corporate income tax returns. We intend to use this firm to assist with enhancing internal controls over financial reporting for income taxes and developing and implementing a remediation plan.
  • Hold quarterly meetings with our new third-party tax provider to discuss changes in tax law, key aspects of our quarterly/annual provisions and required updates to provisions, deciding a course of action and documenting such actions, review and approval of the tax data by senior members of our finance team and final discussion, review and approval of the third-party provider prepared provisions and returns.
  • Provide income tax accounting training to those involved in the review of the tax data from our third-party tax provider.

We will consider the material weaknesses remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

The process of designing and implementing an effective accounting and financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain an accounting and financial reporting system that is adequate to satisfy our reporting obligations. As we continue to evaluate and take actions to improve our internal control over financial reporting, we may determine to take additional actions to address control deficiencies or determine to modify certain of the remediation measures described above.

Changes in Internal Control over Financial Reporting

During the six months ended March 31, 2025, with the exception of the changes described above within this Item 4 there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 2,654 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Except as set forth below, there have been no material changes to the risk factors set forth in Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

Significant political, trade, regulatory developments, and other circumstances beyond our control, could have a material adverse effect on our financial condition or results of operations.

Significant political, trade, or regulatory developments in the jurisdictions in which we sell or purchase our products, including country of origin of such products, are difficult to predict and may create periods of volatility in such markets which may have a material adverse effect on us. Recent changes in U.S. federal policy that affect the geopolitical landscape could give rise to circumstances outside our control that could have negative impacts on our business operations. Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications and delays to the U.S. Tariffs have been announced and further changes are expected to be made in the future, which may include additional sector-based tariffs or other measures. For example, the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. These tariffs do not currently include software, services, intangibles, and other digital services; however, we cannot predict future trade policy or tariffs, including the impact or timing thereof, or whether such services will be subject to any form of tariffs or other restrictions in the future. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. Tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. If disputes and conflicts further escalate, actions by governments in response could be significantly more severe and restrictive. Any of the foregoing could materially adversely affect the Company’s business, results of operations, financial condition and stock price.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-01-01 to 2025-03-31$13.1mus-gaap:Revenues
Revenue6 months2024-10-01 to 2025-03-31$28.8mus-gaap:Revenues
Cost of revenue3 months2025-01-01 to 2025-03-31$8.9mus-gaap:CostOfRevenue
Cost of revenue6 months2024-10-01 to 2025-03-31$20.0mus-gaap:CostOfRevenue
Gross profit3 months2025-01-01 to 2025-03-31$4.2mus-gaap:GrossProfit
Gross profit6 months2024-10-01 to 2025-03-31$8.8mus-gaap:GrossProfit
Research and development3 months2025-01-01 to 2025-03-31$763.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2024-10-01 to 2025-03-31$1.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2025-01-01 to 2025-03-31$4.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2024-10-01 to 2025-03-31$8.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2025-01-01 to 2025-03-31−$994.0kus-gaap:OperatingIncomeLoss
Operating income6 months2024-10-01 to 2025-03-31−$1.3mus-gaap:OperatingIncomeLoss
Income tax3 months2025-01-01 to 2025-03-31−$683.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2024-10-01 to 2025-03-31−$798.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-01-01 to 2025-03-31−$108.0kus-gaap:NetIncomeLoss
Net income6 months2024-10-01 to 2025-03-31$364.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2025-01-01 to 2025-03-31−$0.01us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-10-01 to 2025-03-31$0.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-01-01 to 2025-03-31−$0.01us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-10-01 to 2025-03-31$0.04us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-01-01 to 2025-03-319,343,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-10-01 to 2025-03-319,614,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-10-01 to 2025-03-31$3.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2024-10-01 to 2025-03-31$54.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2024-10-01 to 2025-03-31$593.0kus-gaap:PaymentsOfDividends
Share repurchases6 months2024-10-01 to 2025-03-31$384.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-03-31$29.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-03-31$50.3mus-gaap:AssetsCurrent
Total assetsAt period end2025-03-31$67.1mus-gaap:Assets
Current liabilitiesAt period end2025-03-31$15.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-03-31$19.7mus-gaap:Liabilities
Shareholders' equityAt period end2025-03-31$47.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000356037-25-000036. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.